PHARMACOKINETIC STUDY OF OMEPRAZOLE IN ELDERLY HEALTHY-VOLUNTEERS

被引:30
作者
LANDAHL, S
ANDERSSON, T
LARSSON, M
LERNFELDT, B
LUNDBORG, P
REGARDH, CG
SIXT, E
SKANBERG, I
机构
[1] ASTRA HASSLE AB,CLIN PHARMACOL,S-43183 MOLNDAL,SWEDEN
[2] VASA HOSP,CLIN 4,DEPT GERIATR & LONGTERM CARE MED,GOTHENBURG,SWEDEN
关键词
D O I
10.2165/00003088-199223060-00006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of omeprazole and its metabolites were studied in 8 healthy elderly volunteers using [C-14]omeprazole. In another 6 healthy elderly volunteers, the pharmacokinetics of omeprazole were studied using unlabelled drug. Each volunteer received single doses of omeprazole intravenously (20mg) and orally (40mg) as solutions in a randomised crossover design. The plasma concentrations and urinary excretion of omeprazole and metabolites were followed for 24 and 96h, respectively. The results indicate that the average metabolic capacity of omeprazole is decreased in the elderly compared with that found in earlier studies of healthy young individuals. This was reflected in an increase in bioavailability from 56 to 76%, a reduction in mean systemic clearance by approximately 50% (0.25 L/min) and a prolongation of the mean elimination half-life from 0.7 to 1.0h compared with the young. Despite these findings, the considerable overlap in these parameters between young and old volunteers, together with data from previous pharmacodynamic studies and the wide therapeutic range of omeprazole, indicate that dosage reductions are not needed in the elderly.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 29 条
  • [1] SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS
    ANDERSSON, T
    REGARDH, CG
    DAHLPUUSTINEN, ML
    BERTILSSON, L
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (04) : 415 - 416
  • [2] PHARMACOKINETICS OF VARIOUS SINGLE INTRAVENOUS AND ORAL DOSES OF OMEPRAZOLE
    ANDERSSON, T
    CEDERBERG, C
    REGARDH, CG
    SKANBERG, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) : 195 - 197
  • [3] ANDERSSON T, 1993, IN PRESS CLIN PHARMA
  • [4] A COMPARISON OF 2 DIFFERENT DOSES OF OMEPRAZOLE VERSUS RANITIDINE IN TREATMENT OF DUODENAL-ULCERS
    BARDHAN, KD
    PORRO, GB
    BOSE, K
    DALY, M
    HINCHLIFFE, RFC
    JONSSON, E
    LAZZARONI, M
    NAESDAL, J
    RIKNER, L
    WALAN, A
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1986, 8 (04) : 408 - 413
  • [5] CHEMICAL-REACTIONS OF OMEPRAZOLE AND OMEPRAZOLE ANALOGS .1. A SURVEY OF THE CHEMICAL-TRANSFORMATIONS OF OMEPRAZOLE AND ITS ANALOGS
    BRANDSTROM, A
    LINDBERG, P
    BERGMAN, NA
    ALMINGER, T
    ANKNER, K
    JUNGGREN, U
    LAMM, B
    NORDBERG, P
    ERICKSON, M
    GRUNDEVIK, I
    HAGIN, I
    HOFFMANN, KJ
    JOHANSSON, S
    LARSSON, S
    LOFBERG, I
    OHLSON, K
    PERSSON, B
    SKANBERG, I
    TEKENBERGSHJELTE, L
    [J]. ACTA CHEMICA SCANDINAVICA, 1989, 43 (06): : 536 - 548
  • [6] SUBSTITUTED BENZIMIDAZOLES INHIBIT GASTRIC-ACID SECRETION BY BLOCKING (H++K+)ATPASE
    FELLENIUS, E
    BERGLINDH, T
    SACHS, G
    OLBE, L
    ELANDER, B
    SJOSTRAND, SE
    WALLMARK, B
    [J]. NATURE, 1981, 290 (5802) : 159 - 161
  • [7] GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
  • [8] FULLY AUTOMATED GRADIENT ELUTION LIQUID-CHROMATOGRAPHIC ASSAY OF OMEPRAZOLE AND 2 METABOLITES
    GRUNDEVIK, I
    JERNDAL, G
    BALMER, K
    PERSSON, BA
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1986, 4 (03) : 389 - 398
  • [9] HEALING AND RELAPSE OF SEVERE PEPTIC ESOPHAGITIS AFTER TREATMENT WITH OMEPRAZOLE
    HETZEL, DJ
    DENT, J
    REED, WD
    NARIELVALA, FM
    MACKINNON, M
    MCCARTHY, JH
    MITCHELL, B
    BEVERIDGE, BR
    LAURENCE, BH
    GIBSON, GG
    GRANT, AK
    SHEARMAN, DJC
    WHITEHEAD, R
    BUCKLE, PJ
    [J]. GASTROENTEROLOGY, 1988, 95 (04) : 903 - 912
  • [10] KLINKENBERGKNOL EC, 1987, LANCET, V1, P349